Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Tillotts Pharma
Tillotts Pharma
Activities:
Research & Development
Analysis
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
LUNA 3: Rilzabrutinib Phase III immune thrombocytopenia trial meets primary endpoint
Rilzabrutinib met both the primary endpoint of durable platelet response and various secondary endpoints in patients who were refractory to prior therapy
Memel Biotech and Therabest collaborate to develop exosome-based cell therapies
The partnership will aim to develop, manufacture and distribute novel exosome cell therapies in a range of therapeutic areas
Ipsen and Skyhawk Therapeutics partner to develop RNA-targeting drug candidates
The USD $1.8bn deal will support the development of novel RNA-modulating drugs using Skyhawk's proprietary technology
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Manufacturing
Tillotts launches Octasa tablets in Canada
The introduction of these delayed-release tablets is expected to increase the options for UC patients managed with mesalazine
Finance
Tillotts Pharma launches affiliate in Italy
The subsidiary will be led by Fabrizio Savoldi as MD
Research & Development
Tillotts signs IBD research agreement
Discovery efforts with LabGenius to identify and develop new drug candidates for the treatment of inflammatory bowel diseases
Recruitment
Tillotts Pharma and Zeria appoint new Global Head of Innovation
Manufacturing
Recipharm establishes long-term supply agreement with Tillotts Pharma
Swedish CDMO will handle technology transfer and commercial manufacturing of gastro-enterology products
Finance
Tillotts Pharma sets up affiliates in Czech Republic and UK
To focus on Asacol and Octasa brands
Subscribe now